Clinical studies recruiting near Ashland

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Duluth Clinic Ashland · National Cancer Institute (NCI) · NCT05564390 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Duluth Clinic Ashland · NRG Oncology · NCT05624996 Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C
Phase 3 · Duluth Clinic Ashland · Alliance for Clinical Trials in Oncology · NCT07321652 Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM
Phase 2 · Duluth Clinic Ashland · SWOG Cancer Research Network · NCT06769126 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Duluth Clinic Ashland · NRG Oncology · NCT05946213 Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · Northwest Wisconsin Cancer Center · NRG Oncology · NCT06532279 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Duluth Clinic Ashland · NRG Oncology · NCT05174169 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · King's Daughter's Medical Center · Alliance for Clinical Trials in Oncology · NCT06632327 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Duluth Clinic Ashland · Alliance for Clinical Trials in Oncology · NCT06876714 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Duluth Clinic Ashland · National Cancer Institute (NCI) · NCT04269902 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Duluth Clinic Ashland · Canadian Cancer Trials Group · NCT06592924 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · King's Daughter's Medical Center · NRG Oncology · NCT06748222 Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggress
Phase 2 · Duluth Clinic Ashland · National Cancer Institute (NCI) · NCT06649812 High Relaxivity Contrast Agent for Cardiac MR in the Myocardial Scar Assessment
Phase 4 · Johns Hopkins University · NCT05954559 Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidin
Phase 2 · Duluth Clinic Ashland · National Cancer Institute (NCI) · NCT05554393 Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-S
Phase 3 · Duluth Clinic Ashland · National Cancer Institute (NCI) · NCT06498635 Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectab
Phase 2 · Duluth Clinic Ashland · NRG Oncology · NCT05327686 Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Phase N/A · Duluth Clinic Ashland · Wake Forest University Health Sciences · NCT03998202 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · Duluth Clinic Ashland · Alliance for Clinical Trials in Oncology · NCT05677490 Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With
Phase 3 · Duluth Clinic Ashland · National Cancer Institute (NCI) · NCT07198074 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · Duluth Clinic Ashland · National Cancer Institute (NCI) · NCT06058377 Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NA · Duluth Clinic Ashland · NRG Oncology · NCT05080673 Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The Co
Phase 2 · Duluth Clinic Ashland · National Cancer Institute (NCI) · NCT05564377 Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Phase 2 · Duluth Clinic Ashland · SWOG Cancer Research Network · NCT04205968 Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Trea
Phase 2 · Duluth Clinic Ashland · National Cancer Institute (NCI) · NCT06317649 Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Phase 3 · Duluth Clinic Ashland · Alliance for Clinical Trials in Oncology · NCT05008848 Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (
Phase 2 · Duluth Clinic Ashland · National Cancer Institute (NCI) · NCT06126276 Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head
Phase 2 · Duluth Clinic Ashland · ECOG-ACRIN Cancer Research Group · NCT02734537 Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had
Phase 2/Phase 3 · Duluth Clinic Ashland · SWOG Cancer Research Network · NCT06616584 S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · Duluth Clinic Ashland · SWOG Cancer Research Network · NCT03418961

Look up another city

Look up another condition